Skip to main content
Year archive

NOVA EYE MEDICAL LIMITED — 2018 filings

All 38 regulatory filings released by NOVA EYE MEDICAL LIMITED (EYE) in 2018, sourced directly from the official regulator.

38 Filings
2018 Period
2018 filings (38)
Filing Released Lang
ELX commence trading on USA OTCQX 2 pages 32.9KB
Capital/Financing Update
2018-12-20 English
2018 CEO AGM Presentation 25 pages 753.9KB
AGM Information
2018-11-27 English
2018 AGM Chair Script 13 pages 110.7KB
AGM Information
2018-11-27 English
Sales Update at AGM 2 pages 29.7KB
AGM Information
2018-11-27 English
Results of Meeting 3 pages 38.5KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-27 English
Change in substantial holding 6 pages 166.6KB
Major Shareholding Notification
2018-11-04 English
Ellex 2RT Sales & Marketing Initiatives at AAO 14 pages 1.5MB
Investor Presentation
2018-10-25 English
Annual Report to shareholders/Letter to Shareholders 90 pages 4.8MB
Annual Report
2018-10-25 English
Notice of Annual General Meeting/Proxy Form 14 pages 328.5KB
AGM Information
2018-10-25 English
Ellex appoints Dr David Lubeck as Chief Medical Officer 2 pages 33.1KB
Board/Management Information
2018-10-17 English
ELX US Institutional Roadshow Oct 2018 20 pages 1.7MB
Investor Presentation
2018-10-07 English
ELX LEAD trial investor presentation 18 pages 493.5KB
Investor Presentation
2018-09-20 English
ELX LEAD Clinical trial results 6 pages 106.1KB
Regulatory Filings
2018-09-19 English
ELX LEAD trial investor call 2 pages 52.0KB
Regulatory Filings
2018-09-19 English
Ellex on recent MIGS device withdrawl 2 pages 33.2KB
Regulatory Filings
2018-08-29 English
Full Year Statutory Accounts 90 pages 4.6MB
Annual Report
2018-08-29 English
ELX FY18 ASX Release & Investor Presentation 32 pages 1.9MB
Annual Report
2018-08-29 English
Corporate Governance Statement & 4G 25 pages 204.2KB
Governance Information
2018-08-29 English
Trading Update for Year Ended 30th June 2018 5 pages 280.6KB
Capital/Financing Update
2018-07-26 English
Appointment of President Ellex iTrack 2 pages 36.4KB
Board/Management Information
2018-07-10 English
Appointment of Directors 2 pages 33.6KB
Board/Management Information
2018-07-01 English
Initial Director's Interest Notice 2 pages 186.6KB
Director's Dealing
2018-07-01 English
Change of Director's Interest Notice 2 pages 220.6KB
Director's Dealing
2018-05-31 English
Change in substantial holding 6 pages 167.9KB
Major Shareholding Notification
2018-05-21 English
Director Appointment/Resignation 2 pages 31.7KB
Board/Management Information
2018-05-14 English
Final Director's Interest Notice 2 pages 212.0KB
Director's Dealing
2018-05-14 English
Change of Director's Interest Notice 2 pages 220.8KB
Director's Dealing
2018-05-13 English
Glaucoma Business FY18Q3 Sales Update 5 pages 123.5KB
Capital/Financing Update
2018-04-15 English
Glaucoma Technologies at US Tradeshow ASCRS 2018 4 pages 49.0KB
Regulatory Filings
2018-04-09 English
2RT at European Laser Innovation Forum 2018 7 pages 3.1MB
Regulatory Filings
2018-03-22 English
Ellex Presentation at Oppenheimer Conference 23 pages 11.2MB
Investor Presentation
2018-03-18 English
Additional Financial Information for Half Year 3 pages 81.0KB
Interim / Quarterly Report
2018-03-08 English
Ellex at American Glaucoma Society Meeting, New York City 2 pages 58.3KB
Regulatory Filings
2018-03-06 English
Half Year Accounts for 31 December 2017 21 pages 598.1KB
Interim / Quarterly Report
2018-02-26 English
Trading Update for Half Year Ended 31 December 2017 28 pages 765.7KB
Interim / Quarterly Report
2018-02-04 English
Ceasing to be a substantial holder 4 pages 958.7KB
Regulatory Filings
2018-01-16 English
Becoming a substantial holder 6 pages 1.2MB
Regulatory Filings
2018-01-14 English
Revised Appendix 3B 12 pages 305.6KB
Regulatory Filings
2018-01-03 English